Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting

Stopped slow enrollment and inability to reach the planned sample size within the expected timeframe

Conditions

• Coronary Artery Bypass

Interventions

• DRUG: Roxadustat
• DRUG: Placebo

Sponsor

Peking Union Medical College Hospital

Collaborators

• [object Object]